low back pain. Other chronic pain
Conditions
Interventions
Intervention 1: Intervention group: The first group consisted of 30 patients with low back pain who received 50 mg of pethidine (intravenously). Intervention 2: Intervention group: The second group co
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: All patients who refer to the emergency department of Peymanieh Hospital in Jahrom due to acute low back pain in 2019-2020. Informed consent to attend the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate per minute. Timepoint: In this study, the effect of pethidine, ketrolac and ketrolac-diazepam combination on patients' heart rate was measured at the time before injection, immediately after injection, 5, 10, 20, 60 and 90 minutes after injection. Method of measurement: The heart rate of patients in this study was measured by a nurse in the emergency department and a monitor installed in the emergency department.;The amount of oxygen saturation in the blood. Timepoint: In this study, the effect of pethidine, ketrolac and ketrolac-diazepam combination on patients' blood oxygen saturation was measured at the time before injection, immediately after injection, 5, 10, 20, 60 and 90 minutes after injection. . Method of measurement: Patients' blood oxygen levels were measured using a monitor installed in the emergency department.;Pain. Timepoint: In this study, the effect of pethidine, ketrolac and ketrolac-diazepam combination on patients' pain was measured in the time periods before injection, immediately after injection, 5, 10, 20, 60 and 90 minutes after injection. Method of measurement: Pain variable was measured in this study using Visual Analogue Scale.;Blood pressure. Timepoint: In this study, the effect of pethidine, ketrolac and ketrolac-diazepam combination on patients' blood pressure was measured in the time periods before injection, immediately after injection, 5, 10, 20, 60 and 90 minutes after injection. Method of measurement: In this study, blood pressure was measured using a manual blood pressure monitor and a cuff monitoring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEsmaeal Rayat Dost
Jahrom University of Medical Sciences
Outcome results
None listed